{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:41:09Z","timestamp":1782243669983,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96306-x","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:12:36Z","timestamp":1745172756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-cancer Effects of 1,4-Dialkoxynaphthalene-Imidazolium Salt Derivatives through ERK5 kinase activity inhibition"],"prefix":"10.1038","volume":"15","author":[{"given":"Haena","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh-Thu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8227-8262","authenticated-orcid":false,"given":"Hyunkyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-3018","authenticated-orcid":false,"given":"Ki-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-3597","authenticated-orcid":false,"given":"Hakwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"key":"96306_CR1","doi-asserted-by":"publisher","first-page":"839997","DOI":"10.3389\/fcell.2022.839997","volume":"10","author":"SJ Cook","year":"2022","unstructured":"Cook, S. J. & Lochhead, P. A. ERK5 signalling and resistance to ERK1\/2 pathway therapeutics: The path less travelled?. Front. Cell Dev. Biol. 10, 839997 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"96306_CR2","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/ijms20061426","volume":"20","author":"B Stecca","year":"2019","unstructured":"Stecca, B. & Rovida, E. Impact of ERK5 on the Hallmarks of Cancer. Int. J. Mol. Sci. 20, 1426 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"96306_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.cellsig.2012.07.007","volume":"24","author":"GN Nithianandarajah-Jones","year":"2012","unstructured":"Nithianandarajah-Jones, G. N., Wilm, B., Goldring, C. E. P., M\u00fcller, J. & Cross, M. J. ERK5: Structure, regulation and function. Cell. Signal. 24, 2187\u20132196 (2012).","journal-title":"Cell. Signal."},{"key":"96306_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-023-05569-7","volume":"14","author":"F Ippolito","year":"2023","unstructured":"Ippolito, F. et al. Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity. Cell Death Dis. 14, 32 (2023).","journal-title":"Cell Death Dis."},{"key":"96306_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/cancers14020348","volume":"14","author":"M Monti","year":"2022","unstructured":"Monti, M. et al. Clinical significance and regulation of ERK5 expression and function in cancer. Cancers (Basel). 14, 348 (2022).","journal-title":"Cancers (Basel)."},{"key":"96306_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2014-306761","volume":"64","author":"E Rovida","year":"2015","unstructured":"Rovida, E. et al. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. Gut 64, 1454\u20131465 (2015).","journal-title":"Gut"},{"key":"96306_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ccr.2010.08.008","volume":"18","author":"Q Yang","year":"2010","unstructured":"Yang, Q. et al. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell 18, 258\u2013267 (2010).","journal-title":"Cancer Cell"},{"key":"96306_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41467-020-15031-3","volume":"11","author":"PA Lochhead","year":"2020","unstructured":"Lochhead, P. A. et al. Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors. Nat. Commun. 11, 1383 (2020).","journal-title":"Nat. Commun."},{"key":"96306_CR9","doi-asserted-by":"publisher","first-page":"11865","DOI":"10.1073\/pnas.1609019113","volume":"113","author":"ECK Lin","year":"2016","unstructured":"Lin, E. C. K. et al. ERK5 kinase activity is dispensable for cellular immune response and proliferation. Proc. Natl. Acad. Sci. USA 113, 11865\u201311870 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"96306_CR10","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1042\/BST20190338","volume":"48","author":"SJ Cook","year":"2020","unstructured":"Cook, S. J., Tucker, J. A. & Lochhead, P. A. Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: Be careful what you wish for\u2026. Biochem. Soc. Trans. 48, 1859\u20131875 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"96306_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1107\/S2059798316004502","volume":"72","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. Discovery of a novel allosteric inhibitor-binding site in ERK5: Comparison with the canonical kinase hinge ATP-binding site. Acta Crystallogr. Sect. D Struct Biol. 72, 682\u2013693 (2016).","journal-title":"Acta Crystallogr. Sect. D Struct Biol."},{"key":"96306_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/ml100304b","volume":"2","author":"X Deng","year":"2011","unstructured":"Deng, X. et al. Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a potent and selective inhibitor of big MAP kinase 1. ACS Med. Chem. Lett. 2, 195\u2013200 (2011).","journal-title":"ACS Med. Chem. Lett."},{"key":"96306_CR13","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.apsb.2021.12.022","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy. Acta Pharm. Sin. B. 12, 2171\u20132192 (2022).","journal-title":"Acta Pharm. Sin. B."},{"key":"96306_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fcell.2016.00105","volume":"4","author":"N Gomez","year":"2016","unstructured":"Gomez, N., Erazo, T. & Lizcano, J. M. ERK5 and cell proliferation: Nuclear localization Is what matters. Front. Cell Dev. Biol. 4, 105 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"96306_CR15","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.3390\/molecules26144213","volume":"26","author":"P Sharma","year":"2021","unstructured":"Sharma, P., LaRosa, C., Antwi, J., Govindarajan, R. & Werbovetz, K. A. Imidazoles as potential anticancer agents: An update on recent studies. Molecules 26, 4213 (2021).","journal-title":"Molecules"},{"key":"96306_CR16","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1039\/C4MD00277F","volume":"5","author":"VMS Gangavaram","year":"2014","unstructured":"Gangavaram, V. M. S. et al. Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence. Med. Chem. Commun. 5, 1751\u20131760 (2014).","journal-title":"Med. Chem. Commun."},{"key":"96306_CR17","doi-asserted-by":"crossref","unstructured":"Gujjarappa, R. et al. Overview on biological activities of imidazole derivatives in imidazole-based compounds: Recent advances and applications 135\u2013227 (Springer, 2022). https:\/\/doi.org\/10.1007\/978-981-16-8399-2_6.","DOI":"10.1007\/978-981-16-8399-2_6"},{"key":"96306_CR18","doi-asserted-by":"publisher","first-page":"943879","DOI":"10.3389\/fphar.2022.943879","volume":"13","author":"M Samsuzzaman","year":"2022","unstructured":"Samsuzzaman, M. et al. Identification of a potent NAFLD drug candidate for controlling T2DM-mediated inflammation and secondary damage in vitro and in vivo. Front. Pharmacol. 13, 943879 (2022).","journal-title":"Front. Pharmacol."},{"key":"96306_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/pharmaceutics13030312","volume":"13","author":"J Lee","year":"2021","unstructured":"Lee, J. et al. Antifungal activity of 1,4-dialkoxynaphthalen-2-acyl imidazolium salts by inducing apoptosis of pathogenic candida spp. Pharmaceutics. 13, 312 (2021).","journal-title":"Pharmaceutics."},{"key":"96306_CR20","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/ijms24032713","volume":"24","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. Synthesis of 1,4-Dialkoxynaphthalene-based imidazolium salts and their cytotoxicity in cancer cell lines. Int. J. Mol. Sci. 24, 2713 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"96306_CR21","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.3390\/cimb45070388","volume":"45","author":"J Hwang","year":"2023","unstructured":"Hwang, J., Moon, H., Kim, H. & Kim, K. Y. Identification of a novel ERK5 (MAPK7) inhibitor, MHJ-627, and verification of its potent anticancer efficacy in cervical cancer HeLa cells. Curr. Issues Mol. Biol. 45, 6154\u20136169 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"96306_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.tet.2014.12.043","volume":"71","author":"YS Lee","year":"2015","unstructured":"Lee, Y. S. et al. Significant facilitation of metal-free aerobic oxidative cyclization of imines with water in synthesis of benzimidazoles. Tetrahedron 71, 532\u2013538 (2015).","journal-title":"Tetrahedron"},{"key":"96306_CR23","doi-asserted-by":"publisher","first-page":"116352","DOI":"10.1016\/j.bmc.2021.116352","volume":"46","author":"Z Ma","year":"2021","unstructured":"Ma, Z. et al. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Bioorg. Med. Chem. 46, 116352 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"96306_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1568009620666200115162814","volume":"20","author":"M Cardano","year":"2020","unstructured":"Cardano, M., Tribioli, C. & Prosperi, E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation. Curr. Cancer Drug Targets. 20, 240\u2013252 (2020).","journal-title":"Curr. Cancer Drug Targets."},{"key":"96306_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.canlet.2017.01.034","volume":"392","author":"VT Hoang","year":"2017","unstructured":"Hoang, V. T. et al. Oncogenic signaling of MEK5-ERK5. Cancer Lett. 392, 51\u201359 (2017).","journal-title":"Cancer Lett."},{"key":"96306_CR26","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1021\/acs.jmedchem.3c00072","volume":"66","author":"DC Miller","year":"2023","unstructured":"Miller, D. C. et al. Modulation of ERK5 activity as a therapeutic anti-cancer strategy. J. Med. Chem. 66, 4491\u20134502 (2023).","journal-title":"J. Med. Chem."},{"key":"96306_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie, H., Gagnon, J. & Therrien, M. ERK signalling: A master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol. 21, 607\u2013632 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"96306_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/CritRevOncog.2016016987","volume":"21","author":"L Nonnenmacher","year":"2016","unstructured":"Nonnenmacher, L. et al. Cell death induction in cancer therapy - Past, present, and future. Crit. Rev. Oncog. 21, 253\u2013267 (2016).","journal-title":"Crit. Rev. Oncog."},{"key":"96306_CR29","doi-asserted-by":"publisher","first-page":"742049","DOI":"10.3389\/fcell.2021.742049","volume":"9","author":"A G\u00e1mez-Garc\u00eda","year":"2021","unstructured":"G\u00e1mez-Garc\u00eda, A. et al. ERK5 Inhibition induces autophagy-mediated cancer cell death by activating ER stress. Front. Cell Dev. Biol. 9, 742049 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"96306_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.15283\/ijsc18053","volume":"11","author":"C Kang","year":"2018","unstructured":"Kang, C., Kim, J. S., Kim, C. Y., Kim, E. Y. & Chung, H. M. The Pharmacological inhibition of ERK5 enhances apoptosis in acute myeloid leukemia cells. Int. J. Stem Cells 11, 227\u2013234 (2018).","journal-title":"Int. J. Stem Cells"},{"key":"96306_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/15384101.2021.1922806","volume":"20","author":"N Barnaba","year":"2021","unstructured":"Barnaba, N. & LaRocque, J. R. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma. Cell Cycle 20, 1041\u20131051 (2021).","journal-title":"Cell Cycle"},{"key":"96306_CR32","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"96306_CR33","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller, D. et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42, W32\u2013W38 (2014).","journal-title":"Nucleic Acids Res."},{"key":"96306_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris, G. M. et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639\u20131662 (1998).","journal-title":"J. Comput. Chem."},{"key":"96306_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"96306_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomimetics7040154","volume":"7","author":"M Kim","year":"2022","unstructured":"Kim, M., Kim, J. G. & Kim, K. Y. Trichosanthes kirilowii extract promotes wound healing through the phosphorylation of ERK1\/2 in keratinocytes. Biomimetics 7, 154 (2022).","journal-title":"Biomimetics"},{"key":"96306_CR37","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/molecules28062744","volume":"28","author":"AT Nguyen","year":"2023","unstructured":"Nguyen, A. T. et al. MSF enhances human antimicrobial peptide \u03b2-defensin (HBD2 and HBD3) expression and attenuates inflammation via the NF-\u03baB and p38 signaling pathways. Molecules 28, 2744 (2023).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96306-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T18:12:38Z","timestamp":1745172758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96306-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96306"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96306-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13648"}}